Acrobiosystems for English
icon_bulk_orderConsulta masiva/Pedido rápido
user
  1. Cuadro de mandos
  2. Mi perfil
  3. Mi dirección
  4. Mis pedidos
  5. Afiliación a Acro
Iniciar sesión Registro
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
No hay productos en el carro de la compra
Mi carro|Check Out
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Casa > Properdin

Properdin

Brief Information

Name:Properdin
Target Synonym:Complement factor P,CFP
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

Product> Filter Results
Por estado del producto :
Por categoría de producto :
Por especies :
Por etiqueta :
Por Conjugado::
Cat. No. Especies Descripción del producto Estructura Pureza Característica
PRN-R52H6 Rhesus macaque Rhesus macaque Properdin Protein, His Tag
PRN-R52H6-structure
PRN-R52H6-sds
PRN-M52H5 Mouse Mouse Properdin Protein, His Tag
PRN-M52H5-structure
PRN-M52H5-sds
PRN-H52H3 Human Human Properdin Protein, His Tag
PRN-H52H3-structure
PRN-H52H3-sds
ACRO Quality

Synonym Name

Properdin,Complement factor P,CFP,PFC

Background

Properdin is also known as Complement factor P, CFP, PFC, a positive regulator of the alternate pathway of complement. It binds to and stabilizes the C3- and C5-convertase enzyme complexes. Properdin is produced by many different leukocyte subsets and circulates as cyclic oligomers of monomeric subunits. Properdin on platelet/granulocyte aggregates(PGA) formation are tightly regulated by Factor H, properdin enhances PGA formation via increased production of C5a, and that inhibition of properdin function has therapeutic potential to limit thromboinflammation in diseases characterized by increased PGA formation.

Clinical and Translational Updates

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tarperprumig ALXN-1820 Phase 2 Clinical Alexion Pharmaceuticals Inc Anemia, Sickle Cell Details
NM-5072 NM5072; NM-5072 Phase 1 Clinical NovelMed Therapeutics Inc Hemoglobinuria, Paroxysmal Details
Tarperprumig ALXN-1820 Phase 2 Clinical Alexion Pharmaceuticals Inc Anemia, Sickle Cell Details
NM-5072 NM5072; NM-5072 Phase 1 Clinical NovelMed Therapeutics Inc Hemoglobinuria, Paroxysmal Details

This web search service is supported by Google Inc.

totop
Call us
Call us

Germany+49 800 0826645

United Kingdom+44 808 281 3436

Netherlands+31 800 0224992

Switzerland+41 800 040 012

France+33 800 90 78 85

Sweden+46 20 12 76 94

Denmark+45 80 83 07 62

Belgium+32 800 27 125

Email
Correo electrónico
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
Lichtstrasse 35,4056 Basel, Switzerland
linkedin twitter facebook youtube

Dejar un mensaje

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap